Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Potential.

Area of Science:

• Biochemistry and Structural Biology
• Pharmacology and Drug Discovery
• Computational Chemistry

Background:

• Growing number of experimental G-protein-coupled receptor (GPCR) structures reveal diverse allosteric modulation sites.
• Limited number of drugs targeting these allosteric sites necessitates a deeper understanding for drug discovery.
• Existing methods for identifying allosteric sites require systematic evaluation and standardization.

Purpose of the Study:

• To introduce a systematic annotation scheme for structurally classifying GPCR binding sites.
• To evaluate the performance of different binding site detection methods on GPCR structures.
• To characterize the chemical properties of allosteric ligands and binding sites, particularly extrahelical ones.

Main Methods:

• Developed a GPCR-specific annotation scheme based on receptor class, transmembrane helix contacts, and membrane sublocation.
• Applied the scheme to 107 GPCR structures with small molecule ligands, identifying 24 distinct allosteric binding sites.
• Compared three binding site detection methods (BioGPS, SiteMap, FTMap) and analyzed ligand and binding site properties.

Main Results:

• BioGPS demonstrated superior performance, identifying 22 out of 24 allosteric sites.
• Extrahelical allosteric sites and ligands exhibit distinct chemical features: shallow pockets, low volume, and enrichment of halogens.
• Combining receptor and ligand similarity proves effective for ligandability assessment.

Conclusions:

• The developed annotation scheme provides a standardized, objective framework for comparing allosteric binding sites across GPCRs.
• Understanding the distinct chemical space of extrahelical sites and ligands can guide future drug design efforts.
• This study enhances the potential for targeting GPCR allosteric sites in drug development.